Capecitabine and Margetuximab

About

Membership operator: AND

Therapies: 2

Therapies

Capecitabine (tx:ncit:C1794)

Margetuximab (tx:ncit:C91733)

View API

Therapeutic response

Precision oncology relationships for therapeutic response involving this therapy group.

Organizations
Biomarkers
Cancer types
Therapies
Organizations Biomarkers Cancer types Therapies
FDA (2) HER2-positive Invasive Breast Carcinoma Capecitabine, Margetuximab